Keyphrases
Immune Response
100%
Lentiviral Vector
100%
Long-term Corrections
100%
Native Promoter
100%
Green Fluorescent Protein
33%
Treg
33%
Hemophilia
33%
Factor VIII Activity
33%
Bleeding Phenotype
33%
Hepatocytes
16%
Regulatory T Cells
16%
Gene Expression
16%
Therapeutic Gene
16%
Gene Therapy
16%
Transgene Expression
16%
Therapy Approaches
16%
Promoter Sequence
16%
After Injection
16%
Bioinformatics Analysis
16%
Green Fluorescent Protein Expression
16%
Titer
16%
Gene Delivery
16%
Liver Sinusoidal Endothelial Cells
16%
Hematopoietic Organ
16%
Specific Expression
16%
Secreting Cells
16%
Haemophilia A Mice
16%
Phenotypic Adjustment
16%
Regulatory Elements
16%
Gene Replacement
16%
Codon Optimization
16%
Immune Tolerance Induction
16%
Inhibitor Formation
16%
Therapeutic Factors
16%
Sustained Activity
16%
Blood Loss Reduction
16%
Anti-factor VIII Antibodies
16%
Medicine and Dentistry
Immune Response
100%
Promoter Region
100%
Blood Clotting Factor 8
100%
Lentivirus Vector
54%
Bleeding
27%
Green Fluorescent Protein
27%
Haemophilia A
27%
Protein Expression
9%
Hepatocyte
9%
Disease
9%
Endothelial Cell
9%
Gene Expression
9%
Codon
9%
Gene Targeting
9%
Revertant
9%
Gene Therapy
9%
Regulatory T Cell
9%
Transgene
9%
Immunological Tolerance
9%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Immune Response
100%
Factor VIII
100%
Lentivirus Vector
54%
Green Fluorescent Protein
27%
Regulatory T Cell
27%
Haemophilia A
27%
Protein Expression
9%
Hepatocyte
9%
Gene Expression
9%
Regulatory Element
9%
Transgene
9%
Gene Therapy
9%
Codon
9%
Titer
9%
Immunological Tolerance
9%
Gene Targeting
9%
Revertant
9%
Immunology and Microbiology
Promoter Region
100%
Immune Response
100%
Factor VIII
100%
Lentivirus Vector
54%
Regulatory T Cell
27%
Protein Expression
9%
Immune Tolerance
9%
Gene Expression
9%
Transgene
9%
Titer
9%
Codon
9%
Revertant
9%
Gene Targeting
9%
Immunology
9%